Cisplatin binding

Author: vtrf

August undefined, 2024

WebApr 10, 2024 · Triple-negative breast cancer (TNBC) is one of the most aggressive forms of breast cancer and constitutes 10–20% of all breast cancer cases. Even though platinum-based drugs such as cisplatin and carboplatin are effective in TNBC patients, their toxicity and development of cancer drug resistance often hamper their clinical use. Hence, novel … WebCisplatin is a platinum-based chemotherapeutic that has long since been effective against a variety of solid-cancers, substantially improving the five-year survival rates for cancer patients. Its use has also historically been limited by its adverse drug reactions, or cisplatin-induced toxicities (CITs). Of these reactions, cisplatin-induced nephrotoxicity (CIN), …

Targeted therapy for cisplatin‐resistant lung cancer via …

WebWe have seen how cisplatin binds DNA, and now we want to understand how the binding of cisplatin to DNA leads to programmed cell death. Researchers have found that this … WebThe current accepted paradigm about cisplatin mechanism of action is that the drug induces its cytotoxic properties through binding to nuclear DNA and subsequent interference with normal transcription, and/or DNA replication mechanisms. northern tools hampton

Antineoplastic Drug Administration: Vesicant and Irritant …

WebKinetics of cisplatin binding to cellular DNA and modulations by thiol-blocking agents and thiol drugs. DNA platination by cisplatin (CDDP) was investigated in peripheral blood … WebAug 10, 2024 · Binding of cis -DDP to DNA inhibits replication both in vivo and in vitro, as shown by a variety of assays. Inhibition of replication of SV40 viral DNA in African green monkey cells as a function of the concentration of added cis -DDP is shown in Figure 9.17. WebJun 15, 2024 · Wang et al. indicated that miR-17 targets c-Jun activation domain binding protein 1 (JAB1) to promote tumor growth and cisplatin (DDP) resistance of TNBC . As far as we know, chemotherapy is the standard therapeutic strategy for TNBC, and DDP is the most widely used chemotherapeutic drug for solid tumors. northern tools grand prairie tx

Ribosome Biogenesis Regulator 1 Homolog (RRS1) Promotes Cisplatin …

Cellular responses to Cisplatin-induced DNA damage - PubMed

WebCisplatin crosslinks DNA by binding adjacent guanine bases on a strand. These crosslinks kink the DNA, hampering its normal function and damaging the cell and its genome. … WebJun 20, 2024 · We propose here a new mechanism of cisplatin resistance mediated by glutathione transferase (GST) P1-1, as a cisplatin-binding protein. Our results show … how to safely get out of ketosisWebAug 8, 2010 · Cisplatin is one of the most effective anticancer agents widely used in the treatment of solid tumors. It is generally considered as a cytotoxic drug which kills cancer cells by damaging DNA and inhibiting DNA synthesis. How cells respond to cisplatin-induced DNA damage plays a critical role in deci … how to safely get off of zoloft

"WebSep 1, 2024 · Cisplatin dose not undergo the instantaneously and reversible binding to plasma protein that is characteristic of normal drug-protein binding. Platinum from … " - Cisplatin binding

Cisplatin binding

WebAug 2, 2016 · Our data reveal unexpected cisplatin binding sites on the protein surface that could have general significance: cisplatin fragments − [Pt (NH 3) 2 Cl] +, − [Pt (NH 3 )Cl 2 ], and − [Pt (NH 3) 2 (OH 2 )] 2+ bind … WebJul 24, 2024 · The aim of this work is to identify the cisplatin binding sites on human H-chain ferritin. High-resolution X-ray crystallography reveals that cisplatin binds four …

Did you know?

WebOct 21, 2016 · Where Does Cisplatin Bind? Genome-wide Assay System Detects Cisplatin Action Sites Cisplatin is one of the most widely used agents in cancer chemotherapy. Its … WebAug 19, 2005 · Binding of cisplatin to proteins reduces urinary excretion of platinum, and causes deposition of platinum in tissues. Binding of cisplatin to proteins and enzymes is generally believed to be the cause of several severe side effects exhibited by these drugs, especially ototoxicity and nephrotoxicity.

WebMar 29, 2024 · Cisplatin binds to the copper-binding sites in the N-terminal domain of ATP7B; this binding may be an essential step of cisplatin detoxification involving copper ATPases. COX19 is necessary for the transduction of a SCO1-dependent mitochondrial redox signal that regulates ATP7A-mediated cellular copper efflux. WebSep 1, 2024 · To identify proteins that bind to cisplatin, they synthesized two different platinum-agarose conjugates, one with two amino groups and another with two chlorides attached to platinum that are available for protein binding, and conducted pull-down assays using cochlear and kidney cells.

WebNov 15, 1987 · Two sublines were derived from a human bladder carcinoma continuous cell line (RT112-P), one by exposure to fractionated X-irradiation (RT112-DXR8) and the other by continuous exposure to cisplatin (RT112-CP). RT112-DXR8 cells were 1.6- to 2-fold more sensitive to cisplatin and 2 analogues, carbopla … WebMay 26, 2024 · Using the fluorescent cisplatin analog BODIPY-cisplatin, two-dimensional gel electrophoresis, and mass spectrometry, we identified the protein binding partners in …

WebJan 18, 2024 · Once inside cells, cisplatin undergoes aquation, and the platinum atom of cisplatin binds covalently to the N 7 position of purines resulting in about 65% GpG, …

WebCisplatin is administered through a vein (intravenously or IV) as an infusion. There is no pill form of cisplatin. Cisplatin is an irritant. An irritant is a chemical that can cause inflammation of the vein through which it is given. If cisplatin escapes from the vein it can cause tissue damage. northern tools hawaiiWebSep 27, 2024 · Nausea and Vomiting: cisplatin for injection can cause severe nausea and vomiting. Use highly effective antiemetic premedication [see Dosage and Administration ( 2.1) and Warnings and Precautions ( 5.3 )]. • Myelosuppression: cisplatin for injection can cause severe myelosuppression with fatalities due to infections. northern tools grinderWeb2.4. Screening and characteristics of AM binding to A549/DDP using Cell‐SELEX. Accurate targeting is the key to improving therapeutic effects. Therefore, we used Cell‐SELEX to … how to safely get rid of phoneWeb2.4. Screening and characteristics of AM binding to A549/DDP using Cell‐SELEX. Accurate targeting is the key to improving therapeutic effects. Therefore, we used Cell‐SELEX to screen for AMs in 12 pools (Figure S1). The binding forces of ssDNA from the 12 pools were compared using a cell‐enzyme‐linked oligonucleotide assay. northern tools handheld sandblasterWebMar 25, 2024 · Given that apoptosis resistance is one of the causes of the cisplatin resistance of tumor cells, our aim was to determine the relationship between RRS1 and cisplatin resistance in breast cancer cells. Here, we report that RRS1 is associated with cisplatin resistance in breast cancer cells. northern tool shedsWeb[1] [2] Cisplatin is in the platinum-based antineoplastic family of medications. [2] It works in part by binding to DNA and inhibiting its replication. [2] Cisplatin was discovered in … northern tools hand toolsWebUV/Vis spectroscopy confirms the stoichiometry of binding and shows that cisplatin and iron(III) binding are competitive. The binding of cisplatin has been modelled by using … how to safely get rid of an old computer